The pathway consists of 5-hydroxytryptamine (5-HT) projections from the dorsal raphe nucleus to somatostatin (SOM)-expressing and non-SOM interneurons in the central nucleus of the amygdala, which continue to extend directly towards the lateral habenula, an area known to be involved in depression. Here, SST is linked to depressive disorder.